Neoplasms, Endometrial Completed Phase 2 Trials for Topotecan (DB01030)

Also known as: Endometrial Neoplasm / Endometrial Neoplasms / Endometrial neoplasia / Endometrial neoplasm NOS / Neoplasm endometrium / Neoplasm of endometrium

IndicationStatusPhase
DBCOND0034079 (Neoplasms, Endometrial)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00267488Intravenous Weekly Topotecan In Subjects With Recurrent Or Persistent Endometrial CancerTreatment